Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jupiter Neurosciences (JUNS) Consolidated Net Income (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Consolidated Net Income for 2 consecutive years, with -$2.9 million as the latest value for Q4 2025.

  • Quarterly Consolidated Net Income fell 93.55% to -$2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$8.9 million through Dec 2025, down 168.17% year-over-year, with the annual reading at -$9.0 million for FY2025, 169.18% down from the prior year.
  • Consolidated Net Income for Q4 2025 was -$2.9 million at Jupiter Neurosciences, down from -$2.3 million in the prior quarter.
  • The five-year high for Consolidated Net Income was -$600906.0 in Q3 2024, with the low at -$2.9 million in Q4 2025.